Voluntary Scheme
UK cuts 2026 new-medicine rebate rate to 14.5% under VPAG
United Kingdom; VPAG; Voluntary Scheme for Branded Medicines Pricing Access and Growth; rebate rate; clawback rate; new medicines; NHS; drug pricing; pharmaceutical industry; 2026